Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 629 (ZNF629) is a Krueppel C2H2-type zinc-finger transcription factor encoded by the ZNF629 gene in humans, located on chromosome 16p11.2. It is predicted to function primarily in the nucleus and is involved in the regulation of gene transcription by binding to DNA in a sequence-specific manner, acting as a transcription activator for genes transcribed by RNA polymerase II. ZNF629 belongs to a large family of zinc finger proteins that typically participate in the control of various cellular processes through modulation of gene expression. Disease associations include intellectual developmental disorders and neurodegenerative conditions, but there are no known drugs or therapeutic targeting mechanisms for this protein at present[1][2][3][4][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 629 (ZNF629).